Goldman Thinks Tenet Healthcare Corporation (THC) Is A Long-Term AI Stock Set To Rally Eventually
Express News | Tenet Healthcare Corp : Raymond James Raises Target Price to $195 From $175
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
Barclays Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $171
Barclays analyst Andrew Mok CFA maintains $Tenet Healthcare(THC.US)$ with a buy rating, and maintains the target price at $171.According to TipRanks data, the analyst has a success rate of 53.8% and
Barclays Keeps Their Buy Rating on Tenet Healthcare (THC)
Tenet Healthcare Insider Sold Shares Worth $1,879,734, According to a Recent SEC Filing